^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

BI 1387446

i
Other names: BI 1387446, BI-1387446
Associations
Trials
Company:
Boehringer Ingelheim
Drug class:
STING agonist
Associations
Trials
8ms
Trial completion
|
ezabenlimab (BI 754091) • BI 1387446
4years
P1 data
|
STING (stimulator of interferon response cGAMP interactor 1)
|
ezabenlimab (BI 754091) • BI 1387446
4years
P1 data
|
STING (stimulator of interferon response cGAMP interactor 1)
|
ezabenlimab (BI 754091) • BI 1387446